Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109816554> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3109816554 endingPage "AB5" @default.
- W3109816554 startingPage "AB5" @default.
- W3109816554 abstract "Infliximab (IFX) has been demonstrated to hinder progressive joint destruction induced by PsA. IFX is currently one of the non-contraindicated systemic treatment options during pregnancy. However, little is known about postnatal clearance of infliximab in neonates delivered from psoriasis patients. We measured serum IFX level in an infant delivered from a mother with PsA receiving IFX. A 36-year-old female patient with PsA received 6 mg/kg of IFX every eight weeks. After getting pregnant, she continued it until she was 26 weeks pregnant. She was treated with the same dose of IFX every four weeks from week 18 to 26. She delivered a healthy female baby by caesarean section at week 38 as scheduled. She breastfed her baby. She restarted IFX treatment five weeks after giving birth, and continued IFX treatment every four weeks for one year. Since the patient received IFX treatment during pregnancy and lactation, the serum IFX level in the baby was periodically measured. The concentration of IFX in the serum of the baby was 4.46 μg/mL at 24 days of age; 0.19 μg/mL at 155 days of age; and below the detection level limit at 278 days of age. To the best of our knowledge, there have been no papers reporting the serum IFX levels in a baby delivered from a mother with psoriasis receiving IFX. Further accumulation of case is needed to clarify the safety of IFX in pregnant women with psoriasis and their babies." @default.
- W3109816554 created "2020-12-07" @default.
- W3109816554 creator A5004862834 @default.
- W3109816554 creator A5004876615 @default.
- W3109816554 creator A5010441950 @default.
- W3109816554 creator A5019735694 @default.
- W3109816554 creator A5024148814 @default.
- W3109816554 creator A5030954224 @default.
- W3109816554 creator A5043793590 @default.
- W3109816554 creator A5048042994 @default.
- W3109816554 creator A5055088184 @default.
- W3109816554 creator A5057800581 @default.
- W3109816554 creator A5064712842 @default.
- W3109816554 date "2020-12-01" @default.
- W3109816554 modified "2023-09-25" @default.
- W3109816554 title "13115 Serum infliximab level in an infant delivered from a mother with psoriatic arthritis receiving infliximab" @default.
- W3109816554 doi "https://doi.org/10.1016/j.jaad.2020.06.109" @default.
- W3109816554 hasPublicationYear "2020" @default.
- W3109816554 type Work @default.
- W3109816554 sameAs 3109816554 @default.
- W3109816554 citedByCount "0" @default.
- W3109816554 crossrefType "journal-article" @default.
- W3109816554 hasAuthorship W3109816554A5004862834 @default.
- W3109816554 hasAuthorship W3109816554A5004876615 @default.
- W3109816554 hasAuthorship W3109816554A5010441950 @default.
- W3109816554 hasAuthorship W3109816554A5019735694 @default.
- W3109816554 hasAuthorship W3109816554A5024148814 @default.
- W3109816554 hasAuthorship W3109816554A5030954224 @default.
- W3109816554 hasAuthorship W3109816554A5043793590 @default.
- W3109816554 hasAuthorship W3109816554A5048042994 @default.
- W3109816554 hasAuthorship W3109816554A5055088184 @default.
- W3109816554 hasAuthorship W3109816554A5057800581 @default.
- W3109816554 hasAuthorship W3109816554A5064712842 @default.
- W3109816554 hasConcept C126322002 @default.
- W3109816554 hasConcept C131872663 @default.
- W3109816554 hasConcept C141071460 @default.
- W3109816554 hasConcept C16005928 @default.
- W3109816554 hasConcept C17991360 @default.
- W3109816554 hasConcept C187212893 @default.
- W3109816554 hasConcept C2776260265 @default.
- W3109816554 hasConcept C2777138892 @default.
- W3109816554 hasConcept C2779234561 @default.
- W3109816554 hasConcept C2780564577 @default.
- W3109816554 hasConcept C54355233 @default.
- W3109816554 hasConcept C71924100 @default.
- W3109816554 hasConcept C86803240 @default.
- W3109816554 hasConceptScore W3109816554C126322002 @default.
- W3109816554 hasConceptScore W3109816554C131872663 @default.
- W3109816554 hasConceptScore W3109816554C141071460 @default.
- W3109816554 hasConceptScore W3109816554C16005928 @default.
- W3109816554 hasConceptScore W3109816554C17991360 @default.
- W3109816554 hasConceptScore W3109816554C187212893 @default.
- W3109816554 hasConceptScore W3109816554C2776260265 @default.
- W3109816554 hasConceptScore W3109816554C2777138892 @default.
- W3109816554 hasConceptScore W3109816554C2779234561 @default.
- W3109816554 hasConceptScore W3109816554C2780564577 @default.
- W3109816554 hasConceptScore W3109816554C54355233 @default.
- W3109816554 hasConceptScore W3109816554C71924100 @default.
- W3109816554 hasConceptScore W3109816554C86803240 @default.
- W3109816554 hasIssue "6" @default.
- W3109816554 hasLocation W31098165541 @default.
- W3109816554 hasOpenAccess W3109816554 @default.
- W3109816554 hasPrimaryLocation W31098165541 @default.
- W3109816554 hasRelatedWork W1320415 @default.
- W3109816554 hasRelatedWork W1820575511 @default.
- W3109816554 hasRelatedWork W1965793179 @default.
- W3109816554 hasRelatedWork W2028096017 @default.
- W3109816554 hasRelatedWork W2031157372 @default.
- W3109816554 hasRelatedWork W2103565418 @default.
- W3109816554 hasRelatedWork W2146304976 @default.
- W3109816554 hasRelatedWork W2403221879 @default.
- W3109816554 hasRelatedWork W4255722479 @default.
- W3109816554 hasRelatedWork W4297980453 @default.
- W3109816554 hasVolume "83" @default.
- W3109816554 isParatext "false" @default.
- W3109816554 isRetracted "false" @default.
- W3109816554 magId "3109816554" @default.
- W3109816554 workType "article" @default.